Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Sales (2016 - 2025)

Historic Return on Sales for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to 0.09%.

  • Corcept Therapeutics' Return on Sales fell 1600.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.21% for FY2024, which is 100.0% down from last year.
  • Corcept Therapeutics' Return on Sales amounted to 0.09% in Q3 2025, which was down 1600.0% from 0.18% recorded in Q2 2025.
  • Over the past 5 years, Corcept Therapeutics' Return on Sales peaked at 0.34% during Q3 2022, and registered a low of 0.09% during Q3 2025.
  • In the last 5 years, Corcept Therapeutics' Return on Sales had a median value of 0.23% in 2023 and averaged 0.23%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 700bps in 2021, then plummeted by -1600bps in 2022.
  • Quarter analysis of 5 years shows Corcept Therapeutics' Return on Sales stood at 0.32% in 2021, then tumbled by -50bps to 0.16% in 2022, then surged by 44bps to 0.23% in 2023, then fell by -27bps to 0.17% in 2024, then crashed by -44bps to 0.09% in 2025.
  • Its Return on Sales was 0.09% in Q3 2025, compared to 0.18% in Q2 2025 and 0.13% in Q1 2025.